Bafna Pharmaceuticals Ltd - Stock Price

As on3 Dec 2021
  • BSE : 532989
  • ISIN CODE : INE878I01022
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Bafna Pharmaceuticals Ltd is not traded on BSE/NSE
+4.25 %+5
+2.61 %+3.1

Cash Flow

Parameter MAR 20  MAR 19  YoY %Change
Profit Before Tax-18.83-182.9389.70
Changes In working Capital-129.73110.58-217.32
Cash Flow after changes in Working Capital-343.09-17.87-1819.69
Cash Flow from Operating Activities-343.09-17.87-1819.69
Cash Flow from Investing Activities327.75153.62113.35
Cash Flow from Financing Activities73.01-138.13152.86
Net Cash Inflow / Outflow57.68-2.382523.32
Opening Cash & Cash Equivalents27.1329.51-8.06
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANA
Effect of Foreign Exchange FluctuationsNANANA
Closing Cash & Cash Equivalent84.8127.13212.57

About Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 122. Its current market capitalisation stands at Rs 288.61 Cr. In the latest quarter, company has reported Gross Sales of Rs. 712.18 Cr and Total Income of Rs.719.67 Cr. The company's management includes Akilapriya Chandrashekar Raju, Shanmugam Hemalatha, Jitendra Kumar Pal, R Chitra, Atul Sachdeva, B Kamlesh Kumar, P K Sundaresan.

It is listed on the BSE with a BSE Code of 532989 , NSE with an NSE Symbol of BAFNAPH and ISIN of INE878I01022. It's Registered office is at Bafna Towers,New No 68, Old No.299,Thambu Chetty StreetChennai-600001, Tamil Nadu. Their Registrars are ACC Ltd. It's auditors are Abhay Jain & Co, R Sathyanarayanan & Co

Latest News